THE USEFULNESS of verapamil for myocardial protection from ischemia has been stressed experimentally in preparations in vivo`since Wende et al. ' and Smith et al. ,' using an epicardial ST mapping method,9 reported a reduction in ischemic area induced by the drug. In an experimental preparation of isolated hearts, inhibition of Ca2+ influx across the sarcolemma was indicated as the principal mechanism of the myocardial protection observed. ' 10-13 In contrast, in studies of open-chest dogs receiving the drug systemically, the importance of direct effects on the ischemic myocardium remained unclear.3`6 The effects of the drug on the collateral circulation and on peripheral hemodynamics have also been shown to influence the balance of oxygen demand and supply, 5 1 obscuring the direct effects on the jeopardized myocardium.
In the present study we attempted to elucidate the effects of local administration of verapamil on the energy metabolism and regional contraction of the hy-the peripheral hemodynamic action of the drug was minimized as far as possible. The possibility that the mechanism of myocardial preservation is related to the Ca2+-blocking action of verapamil was examined by comparing the effects of verapamil perfusion with those of hypo-Ca' perfusion.
Materials and methods
Experiments were performed on 34 mongrel dogs weighing 12 to 29 kg that were anesthetized with 25 mg/kg of pentobarbital. Artificial respiration with a mixture of room air and 1 to 2 liters/min of oxygen through a Harvard pump maintained the arterial blood oxygen and carbon dioxide tension at around 100 and 30 mm Hg, respectively, throughout the experiments. After a left thoracotomy and pericardotomy were performed in each dog, the left anterior descending artery (LAD) was dissected at the distal portion of the junction. The first diagonal branch was used as the connecting site for the tip of a bypass tube from the left subclavian artery (figure 1). The silicone tubing used to complete the bypass had an internal diameter of 3 to 4 mm and a three-way stopcock for hypoxic perfusion of the regional myocardium (initially fed by blood from the subclavian artery) and for measurement of the shunt pressure. An electromagnetic flow probe (Nihon Kohden Co.) in the bypass tube allowed measurement of the LAD blood flow during the control period and of the flow rate of artificial perfusates. A pair of microcrystals from an ultrasonic dimension system (Schuessler Co.) was implanted in heart performance, aortic pressure was monitored with a catheter placed in the ascending aorta, aortic flow was measured with an electromagnetic flowmeter with the probe applied around the ascending aorta, and left ventricular pressure and its first derivative were determined with an elastic catheter inserted from the apex. The tracings were recorded simultaneously with a limb lead electrocardiogram on a polygraph (Nihon Kohden RM 6000).
Brief interruption of the blood supply to the regional myocardium was necessary for cannulation of the tip of the bypass tube into the LAD. The time required for this procedure did not exceed 60 sec. After hemodynamic stabilization, validation of reactive hyperemia, and recording of control data, infusion of hypoxic solution into the LAD was begun with a tubing pump (Cole-Parmer Instrument Co.). Throughout the perfusion period the flow rate was maintained at the rate of LAD blood flow during the control period.
By deoxygenation with a gas mixture of 95% N2 and 5% CO2 the oxygen content of the solution was lowered to below 0.1 vol% and the pH was maintained at about 7.4 inhibition of excitation-contraction coupling and reduction in oxygen consumption induced by verapamil in a preparation of isolated papillary muscle. They also reported20 that subcutaneous administration of the drug prevented the development of isoproterenol-induced cardiac necrosis and that this could be related to the preservation of myocardial contents of ATP and CP. In preparations of isolated hearts, Nayler et al.12 and Watts et al. 3 found that verapamil protected myocardial structures and function against the deleterious effects of ischemia and reperfusion by the sparing of ATP in tissue. In these preparations, the effects of the drug on the peripheral circulation can be excluded as a mechanism of action, so the results can be considered evidence for the direct protective effects of the drug.
There was also some evidence to suggest that this protective effect was not achieved by a decrease in heart work.21
However, these results in isolated hearts cannot necessarily be extrapolated to pharmacologic action in preparations in vivo for the reasons pointed out by Ham 23 The present results confirm those presented in previous studies of the isolated heart and, furthermore, provide clear evidence of the importance of the direct action of verapamil on the jeopardized myocardium in a preparation in vivo. Between groups I and II there were no significant differences in hemodynamic indexes throughout the experimental period. Furthermore, the systemic verapamil concentration at 4 min was either negligible, or, at most, lower than the therapeutic plasma concentration. These findings indicate that the peripheral hemodynamic effects of verapamil did not account for the differences in metabolic effects observed in groups I and II.
Critical alterations in the peripheral hemodynamics or the pump function of the heart were absent even in the dogs treated with verapamil in which the coronary venous mixture was not drained. This indicates that intracoronary administration of verapamil may be clinically useful as a supplementary method for protecting the jeopardized myocardium from irreversible ischemic damage before restoration of blood supply to the myocardium by aortocoronary bypass or coronary angioplasty. The antispastic effect on the coronary artery and/or selective suppression of the regional contractility of the ischemic myocardium by the drug4 may offer additional benefits of clinical application. However, there are still many problems to be solved before clinical use can be established; it is not known, for example, whether similar effects can be produced in ischemic preparations. However, the present study does at least indicate the usefulness and safety of intracoronary administration of large doses of verapamil for metabolic preservation of the jeopardized myocardium in a preparation in vivo.
The similar metabolic preservation noted in dogs receiving the Ca2+-free solution supports the view that the primary mechanism of protection of hypoxic myocardium by verapamil is related to Ca 2 metabolism. In isolated muscles perfused with oxygenated solution, the developed tension, which is a major determinant of oxygen consumption,24 was directly affected by the Ca2+ concentration of the perfusate, '9 25. 26 28 demonstrated a decrease in the tension-independent heat production per contraction by Ca2' depletion in rabbit papillary muscle bathed in oxygenated K-H solution. Thus one possibility is that metabolic preservation by verapamil or perfusion with Ca2 +-free solution arises from a decrease in tension-independent consumption of energy in the hypoxic myocardium. The other possibility is that metabolic preservation results from a decrease in development of tension in the hypoxic myocardium, but the degree of segmental shortening does not reflect this decrease quantitatively. It seems reasonable to speculate that the degree of systolic elongation in the hypoxic segment is affected by many factors.29 Besides the developed tension of the involved myocardium, these factors could include the site of microcrystal implantation, the extent of the hypoxic area, the left ventricular systolic pressure, etc.
Consideration of the experimental preparation. In the isolated heart, the degree of reduction in ATP level induced by hypoxic perfusion is generally less than that induced by ischemia, probably as a result of glycolytic inhibition by accumulated metabolites in the latter preparation.3-33 In this context, however, the rapid fall in ATP content in the present preparation of hypoxic perfusion should be noted.
In a recent study34 we examined differences between ischemia and hypoxia using the same experimental preparation as in the present study, and reduction in ATP level after 5 min of regional ischemia was not significantly different from that after 5 min of hypoxia. In this study the rapid fall in ATP level during the initial 5 min of regional hypoxia in spite of the lack of severe metabolite accumulation may be explained, in part, by the relatively high distal coronary pressure that was the result of hypoxic perfusion itself, which probably reduces the contribution of collateral flow.
The energy charge of the normal tissue from the dogs undergoing 5 min of perfusion in the present study, 0.83, is somewhat low compared with that observed in other studies. This may be, at least in part, related to the method we used to obtain high-energy phosphate values, in which the pH of the buffer solution was set to obtain accurate ATP and ADP levels on the chromatogram at the cost of some accuracy in AMP measurement.
